Thema:
Re:Neues zur U5-Impfung von Biontech flat
Autor: Phil Gates
Datum:18.12.21 09:22
Antwort auf:Neues zur U5-Impfung von Biontech von Cerberus

>[https://www.timesofisrael.com/pfizer-testing-3rd-covid-vaccine-dose-for-kids-under-5-after-setback]
>
>"Pfizer said Friday it was changing plans and testing three doses of its COVID-19 vaccine in babies and preschoolers instead of the usual two.
>
>The addition of an extra dose came after a preliminary analysis found 2- to 4-year-olds didn’t have as strong an immune response as expected to special low-dose shots.
>
>Pfizer had planned to release data from its study of children under 5 by the end of the year. It’s not clear how this change will delay the quest to vaccinate the youngest children.
>
>Pfizer and its partner BioNTech said if the three-dose study is successful, they plan to apply for emergency authorization sometime in the first half of 2022."


Mist!


< antworten >